Tags

Type your tag names separated by a space and hit enter

Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis.
Photodermatol Photoimmunol Photomed. 2008 Feb; 24(1):43-5.PP

Abstract

Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%).

Authors+Show Affiliations

Department of Dermatology, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy. rositasaraceno@yahoo.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

18201357

Citation

Saraceno, Rosita, et al. "Monochromatic Excimer Light (308 Nm) in the Treatment of Prurigo Nodularis." Photodermatology, Photoimmunology & Photomedicine, vol. 24, no. 1, 2008, pp. 43-5.
Saraceno R, Nisticò SP, Capriotti E, et al. Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. Photodermatol Photoimmunol Photomed. 2008;24(1):43-5.
Saraceno, R., Nisticò, S. P., Capriotti, E., de Felice, C., Rhodes, L. E., & Chimenti, S. (2008). Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. Photodermatology, Photoimmunology & Photomedicine, 24(1), 43-5. https://doi.org/10.1111/j.1600-0781.2008.00318.x
Saraceno R, et al. Monochromatic Excimer Light (308 Nm) in the Treatment of Prurigo Nodularis. Photodermatol Photoimmunol Photomed. 2008;24(1):43-5. PubMed PMID: 18201357.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. AU - Saraceno,Rosita, AU - Nisticò,Steven P, AU - Capriotti,Elisabetta, AU - de Felice,Catia, AU - Rhodes,Lesley E, AU - Chimenti,Sergio, PY - 2008/1/19/pubmed PY - 2008/4/9/medline PY - 2008/1/19/entrez SP - 43 EP - 5 JF - Photodermatology, photoimmunology & photomedicine JO - Photodermatol Photoimmunol Photomed VL - 24 IS - 1 N2 - Three hundred and eight nanometre excimer light has been reported to be safe and effective in the treatment of chronic skin diseases, but the range of potential applications has not been fully explored. Our objective was to assess the efficacy of monochromatic excimer light (MEL) in the treatment of prurigo nodularis (PN). Eleven patients were enrolled in this pilot study. Patients were treated weekly and an average of eight sessions of MEL was given. Follow-up was 4 months. Partial or complete clinical and histological remission was observed in all patients who completed the study (81%). SN - 0905-4383 UR - https://www.unboundmedicine.com/medline/citation/18201357/Monochromatic_excimer_light__308_nm__in_the_treatment_of_prurigo_nodularis_ L2 - https://doi.org/10.1111/j.1600-0781.2008.00318.x DB - PRIME DP - Unbound Medicine ER -